A study of the delivery-targeting concept applied to antineoplasic drugs active on human osteosarcoma. I: Synthesis and biological activity in nude mice carrying human osteosarcoma xenografts of gem-bisphosphonic methotrexate analoguesSTURTZ, G; APPERE, G; BREISTOL, K et al.European journal of medicinal chemistry. 1992, Vol 27, Num 8, pp 825-833, issn 0223-5234Article

Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agentHENDRIKS, H. R; PLOWMAN, J; BERGER, D. P et al.Annals of oncology. 1992, Vol 3, Num 9, pp 755-763, issn 0923-7534Article

Phagocytosis and lipofuscin accumulation in lymph node macrophagesHENDRIKS, H. R; EESTERMANS, I. L.Mechanisms of ageing and development. 1986, Vol 35, Num 2, pp 161-167, issn 0047-6374Article

Disappearance and reappearance of high endothelial venules and immigrating lymphocytes in lymph nodes deprived of afferent lymphatic vessels: a possible regulatory role of macrophages in lymphocyte migrationHENDRIKS, H. R; EESTERMANS, I. L.European journal of immunology. 1983, Vol 13, Num 8, pp 663-669, issn 0014-2980Article

Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell linesBERGMAN, A. M; KUIPER, C. M; VOOM, D. A et al.Biochemical pharmacology. 2004, Vol 67, Num 3, pp 503-511, issn 0006-2952, 9 p.Article

The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenograftsBOVEN, E; HENDRIKS, H. R; ERKELENS, C. A. M et al.British journal of cancer. 1992, Vol 66, Num 6, pp 1044-1047, issn 0007-0920Article

Macrophages and the activity of high endothelial venules. The effect of interferon-γMEBIUS, R. E; HENDRIKS, H. R; BREVE, J et al.European journal of immunology. 1990, Vol 20, Num 7, pp 1615-1618, issn 0014-2980, 4 p.Article

Rapid decrease in lymphocyte adherence to high endothelial venules in lymph nodes deprived of afferent lymphotic vesselsHENDRIKS, H. R; DUIJVESTIJN, A. M; KRAAL, G et al.European journal of immunology. 1987, Vol 17, Num 12, pp 1691-1695, issn 0014-2980Article

Superior therapeutic efficacy of N-L-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drugBREISTØL, K; HENDRIKS, H. R; FODSTAD, Ø et al.European journal of cancer (1990). 1999, Vol 35, Num 7, pp 1143-1149, issn 0959-8049Article

The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsBREISTØL, K; HENDRIKS, H. R; BERGER, D. P et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1602-1606, issn 0959-8049Conference Paper

Alkyl and alkoxyethyl antineoplastic phospholipidsKOUFAKI, M; POLYCHRONIOU, V; CALOGEROPOULOU, T et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 13, pp 2609-2614, issn 0022-2623Article

Preclinical phase II studies in human tumor xenografts : a European multicenter follow-up studyLANDON, S. P; HENDRIKS, H. R; BRAAKHUIS, B.-J. M et al.Annals of oncology. 1994, Vol 5, Num 5, pp 415-422, issn 0923-7534Article

Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsHENDRIKS, H. R; LANGDON, S; BERGER, D. P et al.European journal of cancer (1990). 1992, Vol 28A, Num 4-5, pp 767-773, issn 0959-8049Article

Interferon-gamma-increased adherence of lymphocytes to high endothelial venulesHENDRIKS, H. R; KORN, C; MEBIUS, R. E et al.Immunology (Oxford). 1989, Vol 68, Num 2, pp 221-226, issn 0019-2805Article

Present and future breast cancer management-bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industryBARTSCH, R; FRINGS, S; HENDRIKS, H. R et al.Annals of oncology. 2014, Vol 25, Num 4, pp 773-780, issn 0923-7534, 8 p.Article

Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivoVARVARESOU, A; IAKOVOU, K; GIKAS, E et al.Anticancer research. 2004, Vol 24, Num 2B, pp 907-919, issn 0250-7005, 13 p.Article

KW-2149 (7,N,[2,[Y,L-glutamylamino]ethyldithioethyl]mitomycin C) : A new mitomycin C analogue activated by serumMASTERS, J. R. W; KNOW, R. J; HARTLEY, J. A et al.Biochemical pharmacology. 1997, Vol 53, Num 3, pp 279-285, issn 0006-2952Article

Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9SMITSKAMP-WILMS, E; HENDRIKS, H. R; PETERS, G. J et al.General pharmacology. 1996, Vol 27, Num 3, pp 421-430, issn 0306-3623, 9 p.Article

EO9 : a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical modelsHENDRIKS, H. R; PIZAO, P. E; HORNSTRA, H. W et al.European journal of cancer. Part A. 1993, Vol 29, Num 6, pp 897-906Article

Mesenteric lymph nodes: cells with surface and cytoplasmic immunoglobulinsSMINIA, T; HENDRIKS, H. R; JANSE, M et al.Virchows Archiv. B, Cell pathology. 1984, Vol 47, Num 2, pp 123-129, issn 0340-6075Article